Clinical Trials List
2025-02-03 - 2029-01-31
Phase III
Recruiting5
ICD-10C15.3
Malignant neoplasm of upper third of esophagus
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9150.0
Malignant neoplasm of cervical esophagus
-
Trial Applicant
Daiichi Sankyo Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- 劉奕廷 無
- Chih-Chieh Yen 無
- Wei-Lun Chang Digestive System Department
- Chia-Jui Yen Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- TA-CHEN HUANG 無
- 莊建淮 無
- 郭弘揚 無
- JHE-CYUAN GUO 無
- Chia-Chi Lin 無
- Ta-Ching Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Ping Hung Division of Hematology & Oncology
- Tien-Hua Chen 無
- Chueh-Chuan Yen 無
- 唐振育 無
- 林泰祺 Division of Ophthalmology
- 翁章旂 Division of Ophthalmology
- 陳宥任 Digestive System Department
- 姜乃榕 無
- 翁敬堯 Division of Radiology
- Yun-Cheng Hsieh Digestive System Department
- 黃宣恩 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
680 participants
